SCHEMBL20150352

SCHEMBL20150352

Cc1ccc(-c2ccc3c4ccc(-c5ccc(C)cc5C)cc4n(-c4cc(C#N)ccc4-c4nc(C)nc(C)n4)c3c2)c(C)c1

nearest known ligand 0.37

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 3/20 0.37
CYP11B2 P19099 3/20 0.37
GRM2 Q14416 1/20 0.35
ITK Q08881 1/20 0.34
S1PR1 P21453 1/20 0.33
CHEK1 O14757 1/20 0.33
KCNH2 Q12809 2/20 0.33
EGLN2 Q96KS0 5/20 0.32
MAP4K1 Q92918 1/20 0.31
NSD2 O96028 1/20 0.31
KDM1A O60341 1/20 0.31
HRH2 P25021 1/20 0.31
HRH1 P35367 1/20 0.31
PDE3B Q13370 1/20 0.31
PDE3A Q14432 1/20 0.31
PTGER4 P35408 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20114687 0.95 PTGER4 (0.35) CYP11B1CYP11B2GRM2ITKS1PR1
SCHEMBL20150393 0.93 CYP11B1 (0.37) CYP11B1CYP11B2GRM2ITKS1PR1
SCHEMBL20150346 0.90 CHEK1 (0.36) CYP11B1CYP11B2GRM2ITKCHEK1
SCHEMBL20114637 0.90 ITK (0.38) GRM2ITKEGLN2
SCHEMBL20150349 0.89 CYP11B1 (0.35) CYP11B1CYP11B2GRM2S1PR1CHEK1
SCHEMBL20150344 0.89 CYP11B1 (0.37) CYP11B1CYP11B2S1PR1CHEK1PTGER4
SCHEMBL20150372 0.89 CYP11B2 (0.34) CYP11B1CYP11B2GRM2ITKS1PR1
SCHEMBL20150413 0.88 PTGER4 (0.35) CYP11B1CYP11B2GRM2S1PR1CHEK1
SCHEMBL20114562 0.88 CHEK1 (0.40) CYP11B1CYP11B2GRM2CHEK1EGLN2
SCHEMBL20114568 0.87 MAPK14 (0.36) CYP11B1CYP11B2GRM2CHEK1KDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10421746-B2 Organic molecules, especially for use in organic optoelectronic devices CYNORA GMBH (DE) 2019-09-24 US disclosed
US-20180134686-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-05-17 US disclosed
US-20180134686-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180134686-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, EPCAM, F12 CYP11B1 1765/4885CYP11B2 1259/4885GRM2 1828/4885
US-10421746-B2 Organic molecules, especially for use in organic optoelectronic devices OR10J3, EPCAM, F12 CYP11B1 1765/4885CYP11B2 1259/4885GRM2 1828/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.